Towards Personalized Treatment of Prostate Cancer: PSMA I&T, a Promising Prostate-Specific Membrane Antigen-Targeted Theranostic Agent

Prostate-specific membrane antigen (PSMA) is a well-established target for nuclear imaging and therapy of prostate cancer (PCa). Radiolabeled small-molecule PSMA inhibitors are excellent candidates for PCa theranostics—they rapidly and efficiently localize in tumor lesions. However, high tracer upta...

Descripción completa

Detalles Bibliográficos
Autores principales: Chatalic, Kristell L.S., Heskamp, Sandra, Konijnenberg, Mark, Molkenboer-Kuenen, Janneke D.M., Franssen, Gerben M., Clahsen-van Groningen, Marian C., Schottelius, Margret, Wester, Hans-Jürgen, van Weerden, Wytske M., Boerman, Otto C., de Jong, Marion
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Ivyspring International Publisher 2016
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860893/
https://www.ncbi.nlm.nih.gov/pubmed/27162555
http://dx.doi.org/10.7150/thno.14744

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4860893/
https://www.ncbi.nlm.nih.gov/pubmed/27162555
http://dx.doi.org/10.7150/thno.14744

Ejemplares similares